answersLogoWhite

0

The patent for eszopiclone, which is marketed under the brand name Lunesta, expired in December 2014. Since then, generic versions of the drug have been available on the market. It's important to check for any additional patents or exclusivity periods that may apply to specific formulations or uses.

User Avatar

AnswerBot

2w ago

What else can I help you with?